<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d185" origId="Cefprozil"><sentence id="DrugDDI.d185.s0" origId="s0" text="Nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporin antibiotics."><entity id="DrugDDI.d185.s0.e0" origId="s0.p6" charOffset="73-99" type="drug" text="aminoglycoside antibiotics"/><entity id="DrugDDI.d185.s0.e1" origId="s0.p8" charOffset="104-129" type="drug" text="cephalosporin antibiotics"/><pair id="DrugDDI.d185.s0.p0" e1="DrugDDI.d185.s0.e0" e2="DrugDDI.d185.s0.e1" interaction="false"/></sentence><sentence id="DrugDDI.d185.s1" origId="s1" text="Concomitant administration of probenecid doubled the AUC for cefprozil."><entity id="DrugDDI.d185.s1.e0" origId="s1.p10" charOffset="30-40" type="drug" text="probenecid"/><entity id="DrugDDI.d185.s1.e1" origId="s1.p13" charOffset="61-70" type="drug" text="cefprozil"/><pair id="DrugDDI.d185.s1.p0" e1="DrugDDI.d185.s1.e0" e2="DrugDDI.d185.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d185.s2" origId="s2" text="The bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid."><entity id="DrugDDI.d185.s2.e0" origId="s2.p16" charOffset="50-59" type="drug" text="cefprozil"/><entity id="DrugDDI.d185.s2.e1" origId="s2.p24" charOffset="118-125" type="drug" text="antacid"/><pair id="DrugDDI.d185.s2.p0" e1="DrugDDI.d185.s2.e0" e2="DrugDDI.d185.s2.e1" interaction="false"/></sentence></document>